|Other names: Neurally mediated syncope, neurocardiogenic syncope|
|Symptoms||Loss of consciousness before which there may be sweating, decreased ability to see, ringing in the ears|
|Types||Vasovagal, situational, carotid sinus syncope|
|Diagnostic method||Based on symptoms after ruling out other possible causes|
|Differential diagnosis||Arrhythmia, orthostatic hypotension, seizure, hypoglycemia|
|Treatment||Avoiding triggers, drinking sufficient fluids, exercise, cardiac pacemaker|
|Frequency||> 1 per 1,000 people per year|
Reflex syncope is a brief loss of consciousness due to a neurologically induced drop in blood pressure. Before an affected person passes out, there may be sweating, a decreased ability to see, or ringing in the ears. Occasionally, the person may twitch while unconscious. Complications of reflex syncope include injury due to a fall.
Reflex syncope is divided into three types: vasovagal, situational, and carotid sinus. Vasovagal syncope is typically triggered by seeing blood, pain, emotional stress, or prolonged standing. Situational syncope is often triggered by urination, swallowing, or coughing. Carotid sinus syncope is due to pressure on the carotid sinus in the neck. The underlying mechanism involves the nervous system slowing the heart rate and dilating blood vessels, resulting in low blood pressure and thus not enough blood flow to the brain. Diagnosis is based on the symptoms after ruling out other possible causes.
Recovery from an episode happens without specific treatment. Prevention of episodes involves avoiding a person's triggers. Drinking sufficient fluids, salt, and exercise may also be useful. If this is insufficient for treating vasovagal syncope, medications such as midodrine or fludrocortisone may be tried. Occasionally, a cardiac pacemaker may be used as treatment. Reflex syncope affects at least 1 in 1,000 people per year. It is the most common type of syncope, making up more than 50% of all cases.
Signs and symptoms
Episodes of vasovagal syncope are typically recurrent and usually occur when the predisposed person is exposed to a specific trigger. Before losing consciousness, the individual frequently experiences early signs or symptoms such as lightheadedness, nausea, the feeling of being extremely hot or cold (accompanied by sweating), ringing in the ears, an uncomfortable feeling in the heart, fuzzy thoughts, confusion, a slight inability to speak or form words (sometimes combined with mild stuttering), weakness and visual disturbances such as lights seeming too bright, fuzzy or tunnel vision, black cloud-like spots in vision, and a feeling of nervousness can occur as well. The symptoms may become more intense over several seconds to several minutes before the loss of consciousness (if it is lost). Onset usually occurs when a person is sitting up or standing.
When people lose consciousness, they fall down (unless prevented from doing so) and, when in this position, effective blood flow to the brain is immediately restored, allowing the person to regain consciousness. If the person does not fall into a fully flat, supine position, and the head remains elevated above the trunk, a state similar to a seizure may result from the blood's inability to return quickly to the brain, and the neurons in the body will fire off and generally cause muscles to twitch very slightly but mostly remain very tense.
The autonomic nervous system's physiological state (see below) leading to loss of consciousness may persist for several minutes, so
- If sufferers try to sit or stand when they wake up, they may pass out again
- The person may be nauseated, pale, and sweaty for several minutes or hours
Reflex syncope occurs in response to a trigger due to dysfunction of the heart rate and blood pressure regulating mechanism. When heart rate slows or blood pressure drops, the resulting lack of blood to the brain causes fainting.
Typical triggers include:
- Prolonged standing
- Emotional stress
- The sight of blood
- Time varying magnetic field (i.e. transcranial magnetic stimulation)
- After or during urination (micturition syncope)
- Straining, such as to have a bowel movement
- Lifting a heavy weight
Regardless of the trigger, the mechanism of syncope is similar in the various vasovagal syncope syndromes. The nucleus tractus solitarii of the brainstem is activated directly or indirectly by the triggering stimulus, resulting in simultaneous enhancement of parasympathetic nervous system (vagal) tone and withdrawal of sympathetic nervous system tone.
This results in a spectrum of hemodynamic responses:
- On one end of the spectrum is the cardioinhibitory response, characterized by a drop in heart rate (negative chronotropic effect) and in contractility (negative inotropic effect) leading to a decrease in cardiac output that is significant enough to result in a loss of consciousness. It is thought that this response results primarily from enhancement in parasympathetic tone.
- On the other end of the spectrum is the vasodepressor response, caused by a drop in blood pressure (to as low as 80/20) without much change in heart rate. This phenomenon occurs due to dilation of the blood vessels, probably as a result of withdrawal of sympathetic nervous system tone.
- The majority of people with vasovagal syncope have a mixed response somewhere between these two ends of the spectrum.
One account for these physiological responses is the Bezold-Jarisch reflex.
In addition to the mechanism described above, a number of other medical conditions may cause syncope. Making the correct diagnosis for loss of consciousness is difficult. The core of the diagnosis of vasovagal syncope rests upon a clear description of a typical pattern of triggers, symptoms, and time course.
In people with recurrent vasovagal syncope, diagnostic accuracy can often be improved with one of the following diagnostic tests:
- A tilt table test (results should be interpreted in the context of patients' clinical presentations and with an understanding of the sensitivity and specificity of the test)
- Implantation of an insertable loop recorder
- A Holter monitor or event monitor
- An echocardiogram
- An electrophysiology study
Treatment for reflex syncope focuses on avoidance of triggers, restoring blood flow to the brain during an impending episode, and measures that interrupt or prevent the pathophysiologic mechanism described above.
- The cornerstone of treatment is avoidance of triggers known to cause syncope in that person. However, research has shown that people show great reductions in vasovagal syncope through exposure-based exercises with therapists if the trigger is mental or emotional, e.g., sight of blood. However, if the trigger is a specific drug, then avoidance is the only treatment.
- A technique known as "applied tension" may be additionally useful in those who have syncope with exposure to blood. The technique is done by tightening the skeletal muscles for about 15 seconds when the exposure occurs and then slowing releasing them. This is then repeated every 30 seconds for a few minutes.
- Because vasovagal syncope causes a decrease in blood pressure, relaxing the entire body as a mode of avoidance is not favorable. A person can move or cross their legs and tighten leg muscles to keep blood pressure from dropping so significantly before an injection.
- Before known triggering events, the affected person may increase consumption of salt and fluids to increase blood volume. Sports drinks or drinks with electrolytes may be helpful.
- People should be educated on how to respond to further episodes of syncope, especially if they experience prodromal warning signs: they should lie down and raise their legs, or at least lower their head to increase blood flow to the brain. At the very least, upon the onset of initial symptoms the patient should try to relocate to a 'safe', perhaps cushioned, location in case of losing consciousness. Positioning themselves in a way where the impact from falling or collapsing would be minimized is ideal. The 'safe' area should be within close proximity, since, time is of the essence and these symptoms usually climax to loss of consciousness within a matter of minutes. If the individual has lost consciousness, he or she should be laid down with his or her head turned to the side. Tight clothing should be loosened. If the inciting factor is known, it should be removed if possible (for instance, the cause of pain).
- Wearing graded compression stockings may be helpful.
- Certain medications may also be helpful:
- Beta blockers (β-adrenergic antagonists) were once the most common medication given; however, they have been shown to be ineffective in a variety of studies and are thus no longer prescribed. In addition, they may cause the syncope by lowering the blood pressure and heart rate.
- Medications which may be effective include: CNS stimulants fludrocortisone, midodrine, SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a syncope is anticipated, atropine epinephrine (adrenaline).
- For people with the cardioinhibitory form of vasovagal syncope, implantation of a permanent pacemaker may be beneficial or even curative.
Types of long-term therapy for vasovagal syncope include
- Preload agents
- Anticholinergic agents
- Negative cardiac inotropes
- Central agents
- Mechanical device
- Discontinuation of medications known to lower blood pressure may be helpful, but stopping antihypertensive drugs can also be dangerous in some people. Taking antihypertensive drugs may worsen the syncope, as the hypertension may have been the body's way to compensate for the low blood pressure.
This section needs expansion. You can help by adding to it. (January 2009)
Brief periods of unconsciousness usually cause no lasting harm to health. Reflex syncope can occur in otherwise healthy individuals, and has many possible causes, often trivial ones such as prolonged standing.
The main danger of vasovagal syncope (or dizzy spells from vertigo) is the risk of injury by falling while unconscious. Medication therapy could possibly prevent future vasovagal responses; however, for some individuals medication is ineffective and they will continue to have fainting episodes.
- Orthostatic hypotension
- Orthostatic intolerance
- Postural orthostatic tachycardia syndrome
- Roemheld Syndrome
- Aydin, MA; Salukhe, TV; Wilke, I; Willems, S (26 October 2010). "Management and therapy of vasovagal syncope: A review". World Journal of Cardiology. 2 (10): 308–15. doi:10.4330/wjc.v2.i10.308. PMC 2998831. PMID 21160608.
- Adkisson, WO; Benditt, DG (September 2017). "Pathophysiology of reflex syncope: A review". Journal of Cardiovascular Electrophysiology. 28 (9): 1088–1097. doi:10.1111/jce.13266. PMID 28776824.
- Brignole, Michele; Benditt, David G. (2011). Syncope: An Evidence-Based Approach. Springer Science & Business Media. p. 158. ISBN 9780857292018.
- Shen, WK; Sheldon, RS; Benditt, DG; Cohen, MI; Forman, DE; Goldberger, ZD; Grubb, BP; Hamdan, MH; Krahn, AD; Link, MS; Olshansky, B; Raj, SR; Sandhu, RK; Sorajja, D; Sun, BC; Yancy, CW (1 August 2017). "2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". Circulation. 136 (5): e25–e59. doi:10.1161/CIR.0000000000000498. PMID 28280232.
- "Syncope Information Page". National Institute of Neurological Disorders and Stroke. Retrieved 9 November 2017.
- "Vasovagal syncope: Causes". MayoClinic.com. 7 August 2010. Retrieved 10 August 2016.
- Rossi S, Hallett M, Rossini PM, Pascual-Leone A (2009). "Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research". Clinical Neurophysiology. 120 (12): 2008–2039. doi:10.1016/j.clinph.2009.08.016. hdl:11572/145680. PMC 3260536. PMID 19833552.
- Blanc JJ, Alboni P, Benditt DG (2015). "Vasovagal syncope in humans and protective reactions in animals". Europace. 17 (3): 345–9. doi:10.1093/europace/euu367. PMID 25662986.
- Alboni P, Alboni M (2014). "Vasovagal Syncope As A Manifestation Of An Evolutionary Selected Trait". Journal of Atrial Fibrillation. 7 (2): 1035. doi:10.4022/jafib.1035 (inactive 22 January 2020). PMC 5135249. PMID 27957092.CS1 maint: DOI inactive as of January 2020 (link)
- Fenton AM, Hammill SC, Rea RF, Low PA, Shen WK (2000). "Vasovagal syncope". Ann. Intern. Med. 133 (9): 714–25. doi:10.7326/0003-4819-133-9-200011070-00014. PMID 11074905.
- Durand, VM; DH Barlow (2006). Essentials of Abnormal Psychology 4th Edition. p. 150. ISBN 978-1111836986. Retrieved 12 August 2016.
- Hersen, Michel (2005). Encyclopedia of Behavior Modification and Cognitive Behavior Therapy. SAGE. p. 30. ISBN 9780761927471.
- Felgoise, Stephanie; Nezu, Arthur M.; Nezu, Christine M.; Reinecke, Mark A. (2006). Encyclopedia of Cognitive Behavior Therapy. Springer Science & Business Media. p. 291. ISBN 9780306485817.
- France CR, France JL, Patterson SM (January 2006). "Blood pressure and cerebral oxygenation responses to skeletal muscle tension: a comparison of two physical maneuvers to prevent vasovagal reactions". Clin Physiol Funct Imaging. 26 (1): 21–5. doi:10.1111/j.1475-097X.2005.00642.x. PMID 16398666.
- Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M, Ku T, Fouad-Tarazi F, Ritchie D, Koshman ML (March 2006). "Prevention of Syncope (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope". Circulation. 113 (9): 1164–70. doi:10.1161/CIRCULATIONAHA.105.535161. PMID 16505178.
- Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sánchez A, Peña G, Moro C (February 2001). "Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study". J. Am. Coll. Cardiol. 37 (2): 554–9. doi:10.1016/S0735-1097(00)01155-4. PMID 11216978.
- Grubb BP, Kosinski D, Mouhaffel A, Pothoulakis A (24 May 2012). "The use of methylphenidate in the treatment of refractory neurocardiogenic syncope". Pacing Clin Electrophysiol. 19 (5): 836–40. doi:10.1111/j.1540-8159.1996.tb03367.x. PMID 8734752.
- Ali Aydin, Muhammet; Salukhe, Tushar; Wilkie, Iris; Willems, Stephan (2010). "Management and therapy of vasovagal syncope: A review". World J Cardiol. 2 (10): 308–15. doi:10.4330/wjc.v2.i10.308. PMC 2998831. PMID 21160608.
- Amy M. Karch. "epinephrine (adrenaline)". 2006 Lippincott's Nursing Drug Guide. Retrieved 12 August 2016.
- "Vasovagal Syncope: What is it?". Archived from the original on 3 January 2014. Retrieved 11 August 2016.
- "Vasovagal Syncope Prognosis". MDGuidelines. Retrieved 11 August 2016.